- Dana-Farber researchers have found that a combination of two already-in-use drugs may have an effect on stopping the growth of the most common genetic subtype of lung cancer setting the stage for clinical trials.
Tags: LungCancer, TargetedTherapy
- Researchers at Dana-Farber have developed a tool to help predict how a patient’s tumor is likely to behave and which of several possible treatments is most likely to be effective.
Tags: BreastCancer, Genetics
- "Beige" fat cells found in healthy subcutaneous fat play a critical role in protecting the body against the disease risks of obesity in mice, report researchers at Dana-Farber Cancer Institute, who say their study findings may have implications for therapy of obesity-related illness in humans.
- The most comprehensive genetic study to date of the blood cancer multiple myeloma has revealed that the genetic landscape of the disease may be more complicated than previously thought.
Tags: BasicResearch, MultipleMyeloma, Genetics
- A $30 million gift from Albert A. Marcotte, PhD, will support Dana-Farber Cancer Institute's Capital Projects Campaign to expand research and clinical space. This transformational gift will also create the Marcotte Center for Cancer Research at Dana-Farber and advance strategic cancer research initiatives underway at the Institute.
Tags: JimmyFund, Development
- Scientists have identified a mutated gene that causes a type of benign brain tumor that can have devastating lifelong effects. It may be possible to attack the tumors with targeted drugs already in use for other tumors.
Tags: TargetedTherapy, BrainTumors
- Studies in zebrafish show that a 50-year-old antipsychotic medication can actively combat the cells of a difficult-to-treat form of acute lymphoblastic leukemia (ALL).
- Ludwig Cancer Research, on behalf of its founder, Daniel K. Ludwig, has given Harvard Medical School $90 million to spur innovative scientific inquiry and discovery in a newly expanded center. The Ludwig Center at Harvard will be co-directed by Joan Brugge, PhD, of Harvard Medical School and George Demetri, MD, of Dana-Farber.
Tags: BasicResearch, Development
- The New Year is a great time to add some healthy habits into a daily routine. Maintaining good health doesn't have to be hard. Experts at Dana-Farber Cancer Institute offer seven easy strategies that can help just about anyone get on the road to good health and possibly help reduce cancer risk.
Tags: Exercise, Nutrition, Smoking, Prevention
- Dana-Farber scientists identify a genetic flaw that drives some ovarian cancers, which could assist in identifying treatments for ovarian cancer patients.
Tags: Genomics, OvarianCancer, GynecologicCancers
Showing 21-30 of 487 items